Trial intelligence / Profile preview

Zolpidem sublingual film versus zolpidem tablet for chronic insomnia

IRCT20180120038450N3Phase 3Completed

Sponsor
Kermanshah University of Medical Sciences
Start
Jan 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-blind trial of zolpidem in Insomnia (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Sleep quality. Started Jan 2022; status: completed.

02

Drugs

zolpidem
03

Conditions

Insomnia

Beyond the preview

Go deeper on IRCT20180120038450N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180120038450N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call